X

Xaira Therapeutics

Biotechnology Research · South San Francisco, United States · 500 employees

29 Decision makers
+7 New (6 months)
500 Employees
2023 Founded

Organizational Chart of Xaira Therapeutics

Roles identified within Xaira Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Xaira Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Xaira Therapeutics by function

General management

Human resources

See all Xaira Therapeutics contacts on Zeliq

Decision makers at Xaira Therapeutics

29 identified 12 C-Level 2 VP 15 Directors +7 new (6 months)
See them on Zeliq →

Departments actively hiring 4 departments

General management
Medical
Project management
Research

These departments at Xaira Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Xaira Therapeutics

Funding

Last round Series A · $1.0B
Total funding $1.0B (2 rounds)
Corporate Round N/A Jan 2023
Series A $1.0B Apr 2024

Latest news at Xaira Therapeutics

  1. Appointment

    New Director, Analytical Development appointed — Research

  2. Appointment

    New Director, Bioanalytical Sciences appointed — Research

  3. Appointment

    New Senior Director, Protein Engineering appointed — Research

  4. Appointment

    New Senior Director, Project Management appointed — Project management

  5. Appointment

    New Executive Director appointed — General management

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
97
Technical
19
Consulting
14
Hiring General Management
12
Other
8
HR
6
Administrative
4
Operations
4

How to prospect Xaira Therapeutics's departments

Research

With 97 people, this is the organisation's biggest team, and it is hiring. Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Technical

The company's second-largest department (19 people). Skip the marketing speak: these decision makers expect precise use cases, documentation and a quick proof of value.

Consulting

This department counts 14 people. Billable time is the key metric: anything that reduces non-billable work deserves a spot in your opener.

General Management

This 12-person department is actively recruiting. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Other

8 people work in this department. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Project Management

Hiring is underway in this team of 1 people. These profiles own delivery: anything that de-risks a milestone gets their attention.

Try the Zeliq email finder demo →

FAQ Xaira Therapeutics

Who runs Xaira Therapeutics?

The highest-ranking leadership role identified at Xaira Therapeutics is “Co-founder”, based on public data updated 25 Oct 2026.

How many decision makers does Xaira Therapeutics have?

29 decision makers identified, including 12 at executive level.

How do I contact a decision maker at Xaira Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Xaira Therapeutics?

General management, Medical and Project management, based on published job offers as of 25 Oct 2026.

Companies similar to Xaira Therapeutics

More companies to explore

Biotechnology Research · United States

Also in South San Francisco

All Biotechnology Research companies in United States →

About Xaira Therapeutics

Xaira Therapeutics operates in the Biotechnology Research industry, headquartered in South San Francisco, United States. Founded in 2023, the company employs approximately 500 people. Xaira Therapeutics belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Xaira Therapeutics is a B2B company, primarily serving business clients and professional organisations. The company has secured 2 rounds of funding totalling $1.0B. This profile compiles key information about Xaira Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Xaira Therapeutics operates in the Biotechnology Research segment, part of the broader Professional Services sector. As a B2B company, Xaira Therapeutics primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.